megestrol acetate has been researched along with ketoconazole in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Albert, J; Geller, J; Liu, J | 1 |
| Albert, J; Berry, CC; Fay, W; Geller, J; Liu, J | 1 |
| Fair, WR; Sogani, PC | 1 |
| Albert, J; Geller, J | 1 |
| Albert, J; Berry, CC; Fay, W; Geller, J; Liu, J; Weis, P | 1 |
| Conzen, SD; Greene, GL; House, L; Isikbay, M; Mirkov, S; Ramirez, J; Ratain, MJ; Sachleben, JR; Seminerio, MJ; Singhal, H; Skor, M; Vander Griend, D | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 review(s) available for megestrol acetate and ketoconazole
| Article | Year |
|---|---|
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Estrogens; Flutamide; Glucocorticoids; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Spironolactone; Time Factors | 1987 |
1 trial(s) available for megestrol acetate and ketoconazole
| Article | Year |
|---|---|
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Estrogens; Flutamide; Glucocorticoids; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Spironolactone; Time Factors | 1987 |
11 other study(ies) available for megestrol acetate and ketoconazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of androgen blockade with ketoconazole and megestrol acetate on human prostatic protein patterns.
Topics: Androgen Antagonists; Androgens; Cell Separation; Electrophoresis, Polyacrylamide Gel; Epithelium; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Methionine; Prostate; Prostatic Hyperplasia; Protein Biosynthesis | 1986 |
Effect of antiandrogen and/or antiestrogen blockade on human prostate epithelial and stromal cell protein synthesis.
Topics: Dihydrotestosterone; Epithelium; Humans; Ketoconazole; Kinetics; Male; Megestrol; Megestrol Acetate; Prostate; Prostatic Hyperplasia; Protein Biosynthesis; Tamoxifen | 1986 |
Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH).
Topics: Androgen Antagonists; Castration; Combined Modality Therapy; Diethylstilbestrol; Dihydrotestosterone; Drug Combinations; Humans; Hyperplasia; Ketoconazole; Male; Megestrol; Megestrol Acetate; Orchiectomy; Prostate; Tissue Distribution | 1987 |
Relationship between human prostatic epithelial cell protein synthesis and tissue dihydrotestosterone level.
Topics: Aged; Dihydrotestosterone; Epithelium; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Prostate; Protein Biosynthesis; Tamoxifen | 1987 |
Metabolism of megestrol acetate in vitro and the role of oxidative metabolites.
Topics: Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Glucuronides; Humans; Ketoconazole; Kinetics; Megestrol Acetate; Metabolome; Microsomes, Liver; Oxidation-Reduction; Prostate-Specific Antigen; Proton Magnetic Resonance Spectroscopy; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Substrate Specificity; Troleandomycin | 2018 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |